News for PureTech Health plc (PTCHF)

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) (”œPureTech” or the ”œCompany”), a clinical-stage biotherapeutics company dedicated to changin

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) (”œPureTech” or the ”œCompany”), a clinical-stage biotherapeutics company dedicated to changin

\nCash Position: $366.8 million at the PureTech level at the end of 2024, compared to $326 million at the end of 2023.Consolidated Cash Position: $367.3 million

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) (”œPureTech” or the ”œCompany”), a clinical-stage biotherapeutics company dedicated to changin

The following slide deck was published by PureTech Health plc in conjunction with their 2024 Q4 earnings call.

PureTech Health plc (NASDAQ:PRTC) Q4 2024 Earnings Call April 30, 2025 9:00 AM ETCompany ParticipantsAllison Mead Talbot - Senior Vice President,...

Key Highlights: PureTech Health (PRTC) posts an impressive 45% growth in annual revenue. Analysts project a substantial price target upside, implying a p

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (”œPureTech” or the ”œCompany”) today announces its results for the year ended December 31, 2024, as well a

PureTech Health (PRTC) reports a robust cash position of $366.8 million as of December 31, 2024, with projections to fund operations till at least 2027.

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results

PureTech Health (PRTC) to announce its 2024 annual financial results on April 30, 2025. The company will host a conference call and webcast at 9:00 AM E

Invesco Ltd: Form 8.3 - PureTech Health PLC; Opening Position disclosure

U.S. stock futures were higher this morning, with the Dow futures gaining more than 900 points on Tuesday. Shares of The Greenbrier Companies, Inc. GBX fell sh...

**media[588883]**

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Enti

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the li

On December 31, 2024, CITIGROUP INC (Trades, Portfolio) executed a significant transaction by acquiring 10,703,044 shares of PureTech Health PLC. This acquisiti

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the li

Vedanta's VE303 shows promise in Phase 2 study for rCDI